指南与共识肿瘤 PET/CT

是时候将PET/CT纳入直肠癌指南了吗?

Is It Time to Introduce PET/CT in Rectal Cancer Guidelines?
指南 / 共识 · Clin Nucl Med · 2020-01-01

PET/CT不推荐用于随访或监测。文献显示PET/CT在某些情况下也有较高诊断准确性,本文旨在强调指南与文献的差异。

要点

  • 指南建议在CEA升高或CT/MRI/活检证实的异时性转移的复发评估中考虑PET/CT。
  • 指南不推荐PET/CT用于直肠癌的随访或监测。

核心结论

  • 综述旨在强调当前国际指南与科学文献在PET/CT用于直肠癌方面的差异。

研究设计与样本

  • 综述文章,检索范围未在原文中报告。

主要发现

  • 文献仔细评估显示PET/CT在某些情况下也可使用,并具有显著水平的诊断准确性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

At the moment, international guidelines for rectal cancer suggest to consider F-FDG PET/CT scan in a few conditions: (1) at disease presentation in case of suspected or proven metastatic synchronous adenocarcinoma with potentially curable M1 disease; (2) in the recurrence workup for serial carcinoembryonic antigen level elevation; (3) in the recurrence workup with metachronous metastases documented by CT, MRI, or biopsy; (4) in case of strong contraindication to IV contrast agent administration; and (5) to evaluate an equivocal finding on a contrast-enhanced CT or MRI. PET/CT is not indicated in the follow-up or surveillance of rectal cancer. On the other hand, an attentive evaluation of the literature shows that PET/CT may also be used in some circumstances with significant levels of diagnostic accuracy. This review article aims to emphasize differences between current international guidelines and scientific literature in the role of PET/CT in rectal cancer.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Maffione AM, Montesi G, Caroli P, et al. Is It Time to Introduce PET/CT in Rectal Cancer Guidelines? Clin Nucl Med. 2020. PMID: 32558716. doi:10.1097/RLU.0000000000003132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。